#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Kawasaki's disease Acute promyelocytic leukaemia Retinopathy of prematurity Immune thrombocytopenia Non-Hodgkin's lymphoma unspecified histology indolent Congenital aplastic anaemia Transitional cell cancer of the renal pelvis and ureter Acute leukaemia Desmoplastic small round cell tumour Enteritis Anaplastic thyroid cancer Uveal melanoma Multiple system atrophy Neurodermatitis Adenocarcinoma pancreas More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome – Treatment Hepatoblastoma – Basic Information Primary immunodeficiency syndrome – Treatment Primary mediastinal large B-cell lymphoma – Basic Information Pleural mesothelioma malignant – Life with Disease Idiopathic inflammatory myopathy Primary biliary cholangitis – Diagnostics Arterial tortuosity syndrome Alport’s syndrome – Trials in Disease Richter’s syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aminocaproic Acid Resatorvid M2Rlab Atl001 Milnacipran Hydrochloride 19Cp02 LY3537031 Elenestinib Phosphate Gad20-209-Fsp-A4 Leuprorelin Pritelivir GRNA-001 Mr0005 Xtmab-16 Calcium Chloride Dihydrate Teprotumumab Bjt-778 Estriol Glycerol Phenylbutyrate Human Coagulation Factor X More therapies…

    Learn about Your Condition

    Ejection fraction normal Supraventricular tachycardia Bone sarcoma Postoperative delirium Ear discomfort Non-Hodgkin's lymphoma Dupuytren's contracture Hepatitis alcoholic Thyroid disorder Senile dementia Hodgkin's disease recurrent Triple positive breast cancer Pre-eclampsia Fibrosarcoma Cataract More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Elisabeth-TweeSteden Ziekenhuis

Elisabeth-TweeSteden Ziekenhuis

Hilvarenbeekse Weg 60, Tilburg, 5022, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Discontinuation of methotrexate (drug combination) in rheumatoid arthritis patients using TNF inhibitors

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Adalimumab
    • Certolizumab Pegol
    • Etanercept
    The Netherlands

  • Study on Oral Antibiotics Moxifloxacin, Linezolid, and Metronidazole for Patients with Bacterial Brain Abscess

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Brain abscess
    Investigated Drugs:
    • Meropenem Anhydrous
    • Moxifloxacin Hydrochloride
    • Ceftriaxone Sodium
    Denmark France The Netherlands Sweden

  • Study on Personalized Dosing of Natalizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Natalizumab
    The Netherlands

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!